A citation-based method for searching scientific literature

Alhassane Diallo, Heike Jacobi, Arron Cook, Robyn Labrum, Alexandra Durr, Alexis Brice, Perrine Charles, Cecilia Marelli, Caterina Mariotti, Lorenzo Nanetti, Marta Panzeri, Maria Rakowicz, Anna Sobanska, Anna Sulek, Tanja Schmitz-Hübsch, Ludger Schöls, Holger Hengel, Bela Melegh, Alessandro Filla, Antonella Antenora, Jon Infante, José Berciano, Bart P van de Warrenburg, Dagmar Timmann, Sylvia Boesch, Massimo Pandolfo, Jörg B Schulz, Peter Bauer, Paola Giunti, Jun-Suk Kang, Thomas Klockgether, Sophie Tezenas du Montcel. Lancet Neurol 2018
Times Cited: 45







List of co-cited articles
504 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
37

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
139
35

Spinocerebellar ataxia.
Thomas Klockgether, Caterina Mariotti, Henry L Paulson. Nat Rev Dis Primers 2019
188
35

Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Henry L Paulson, Vikram G Shakkottai, H Brent Clark, Harry T Orr. Nat Rev Neurosci 2017
153
24

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
305
24

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
109
22

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
175
22


Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
Tetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, Christopher M Gomez, George R Wilmot, Jeremy D Schmahmann, Sarah H Ying, Theresa A Zesiewicz, Henry L Paulson, Vikram G Shakkottai,[...]. Orphanet J Rare Dis 2013
81
20

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
93
17

The natural history of degenerative ataxia: a retrospective study in 466 patients.
T Klockgether, R Lüdtke, B Kramer, M Abele, K Bürk, L Schöls, O Riess, F Laccone, S Boesch, I Lopes-Cendes,[...]. Brain 1998
234
15

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Theresa A Zesiewicz, George Wilmot, Sheng-Han Kuo, Susan Perlman, Patricia E Greenstein, Sarah H Ying, Tetsuo Ashizawa, S H Subramony, Jeremy D Schmahmann, K P Figueroa,[...]. Neurology 2018
56
15

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.
Sophie Tezenas du Montcel, Alexandra Durr, Peter Bauer, Karla P Figueroa, Yaeko Ichikawa, Alessandro Brussino, Sylvie Forlani, Maria Rakowicz, Ludger Schöls, Caterina Mariotti,[...]. Brain 2014
101
15

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis,[...]. Nature 2017
173
15

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin, Lauren R Moore, Ravi Chopra, Robert Komlo, Megan McKenzie, Kate G Blumenstein, Hien Zhao, Holly B Kordasiewicz, Vikram G Shakkottai, Henry L Paulson. Ann Neurol 2018
77
15

Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.
Kathrin Reetz, Roberto Rodríguez-Labrada, Imis Dogan, Shahram Mirzazade, Sandro Romanzetti, Jörg B Schulz, Edilia M Cruz-Rivas, Jose A Alvarez-Cuesta, Raul Aguilera Rodríguez, Yanetza Gonzalez Zaldivar,[...]. Ann Clin Transl Neurol 2018
27
25

Brain pathology of spinocerebellar ataxias.
Kay Seidel, Sonny Siswanto, Ewout R P Brunt, Wilfred den Dunnen, Horst-Werner Korf, Udo Rüb. Acta Neuropathol 2012
230
15

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
H Jacobi, P Bauer, P Giunti, R Labrum, M G Sweeney, P Charles, A Dürr, C Marelli, C Globas, C Linnemann,[...]. Neurology 2011
129
15

Targeting potassium channels to treat cerebellar ataxia.
David D Bushart, Ravi Chopra, Vikrant Singh, Geoffrey G Murphy, Heike Wulff, Vikram G Shakkottai. Ann Clin Transl Neurol 2018
37
16

Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.
Carlo Wilke, Friedemann Bender, Stefanie N Hayer, Kathrin Brockmann, Ludger Schöls, Jens Kuhle, Matthis Synofzik. J Neurol 2018
38
15

Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
James M Joers, Dinesh K Deelchand, Tianmeng Lyu, Uzay E Emir, Diane Hutter, Christopher M Gomez, Khalaf O Bushara, Lynn E Eberly, Gülin Öz. Ann Neurol 2018
42
14

Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
Isaac M Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, Daisy Rinaldi, Elodie Petit, Romain Valabregue, Alexis Brice, Alexandra Durr, Fanny Mochel. Neuroimage Clin 2018
44
13

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
117
13

Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, Anna Lehmann, Agnes Juzek, Maria Rakowicz, Romana Boguslawska, Ludger Schöls, Christoph Linnemann, Caterina Mariotti,[...]. Brain 2013
89
13

The cerebellar cognitive affective/Schmahmann syndrome scale.
Franziska Hoche, Xavier Guell, Mark G Vangel, Janet C Sherman, Jeremy D Schmahmann. Brain 2018
168
13

Responsiveness of different rating instruments in spinocerebellar ataxia patients.
T Schmitz-Hübsch, R Fimmers, M Rakowicz, R Rola, E Zdzienicka, R Fancellu, C Mariotti, C Linnemann, L Schöls, D Timmann,[...]. Neurology 2010
102
13

Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
Sophie Tezenas du Montcel, Perrine Charles, Pascale Ribai, Cyril Goizet, Alice Le Bayon, Pierre Labauge, Lucie Guyant-Maréchal, Sylvie Forlani, Celine Jauffret, Nadia Vandenberghe,[...]. Brain 2008
60
13

Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.
Maria do Carmo Costa, Katiuska Luna-Cancalon, Svetlana Fischer, Naila S Ashraf, Michelle Ouyang, Rahil M Dharia, Lucas Martin-Fishman, Yemen Yang, Vikram G Shakkottai, Beverly L Davidson,[...]. Mol Ther 2013
73
13

Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome.
Florian Bodranghien, Amy Bastian, Carlo Casali, Mark Hallett, Elan D Louis, Mario Manto, Peter Mariën, Dennis A Nowak, Jeremy D Schmahmann, Mariano Serrao,[...]. Cerebellum 2016
163
13

Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials.
Roberto Rodríguez-Labrada, Luis Velázquez-Pérez, Georg Auburger, Ulf Ziemann, Nalia Canales-Ochoa, Jacqueline Medrano-Montero, Yaimeé Vázquez-Mojena, Yanetza González-Zaldivar. Mov Disord 2016
27
18

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
33
15

Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. J Neurol 2018
18
27

Safety and efficacy of valproic acid treatment in SCA3/MJD patients.
Li-Fang Lei, Guo-Ping Yang, Jun-Ling Wang, De-Maw Chuang, Wei-Hong Song, Bei-Sha Tang, Hong Jiang. Parkinsonism Relat Disord 2016
37
13

Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).
W Scherzed, E R Brunt, H Heinsen, R A de Vos, K Seidel, K Bürk, L Schöls, G Auburger, D Del Turco, T Deller,[...]. Cerebellum 2012
65
11

Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
A Dürr, G Stevanin, G Cancel, C Duyckaerts, N Abbas, O Didierjean, H Chneiweiss, A Benomar, O Lyon-Caen, J Julien,[...]. Ann Neurol 1996
348
11

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
166
11

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
Andrew C Elden, Hyung-Jun Kim, Michael P Hart, Alice S Chen-Plotkin, Brian S Johnson, Xiaodong Fang, Maria Armakola, Felix Geser, Robert Greene, Min Min Lu,[...]. Nature 2010
813
11

Depression comorbidity in spinocerebellar ataxia.
Tanja Schmitz-Hübsch, Mathieu Coudert, Sophie Tezenas du Montcel, Paola Giunti, Robyn Labrum, Alexandra Dürr, Pascale Ribai, Perrine Charles, Christoph Linnemann, Ludger Schöls,[...]. Mov Disord 2011
53
11

Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study.
C Gaspar, I Lopes-Cendes, S Hayes, J Goto, K Arvidsson, A Dias, I Silveira, P Maciel, P Coutinho, M Lima,[...]. Am J Hum Genet 2001
86
11

In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
Polina A Egorova, Olga A Zakharova, Olga L Vlasova, Ilya B Bezprozvanny. J Neurophysiol 2016
41
12

Dystonia and ataxia progression in spinocerebellar ataxias.
Pei-Hsin Kuo, Shi-Rui Gan, Jie Wang, Raymond Y Lo, Karla P Figueroa, Darya Tomishon, Stefan M Pulst, Susan Perlman, George Wilmot, Christopher M Gomez,[...]. Parkinsonism Relat Disord 2017
26
19

The Initial Symptom and Motor Progression in Spinocerebellar Ataxias.
Lan Luo, Jie Wang, Raymond Y Lo, Karla P Figueroa, Stefan M Pulst, Pei-Hsin Kuo, Susan Perlman, George Wilmot, Christopher M Gomez, Jeremy Schmahmann,[...]. Cerebellum 2017
27
18

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
56
11

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
11

Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.
H Jacobi, M Rakowicz, R Rola, R Fancellu, C Mariotti, P Charles, A Dürr, M Küper, D Timmann, C Linnemann,[...]. Cerebellum 2013
72
11

Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles.
Jillian Friedrich, Holly B Kordasiewicz, Brennon O'Callaghan, Hillary P Handler, Carmen Wagener, Lisa Duvick, Eric E Swayze, Orion Rainwater, Bente Hofstra, Michael Benneyworth,[...]. JCI Insight 2018
54
11

Spinocerebellar ataxia: an update.
Roisin Sullivan, Wai Yan Yau, Emer O'Connor, Henry Houlden. J Neurol 2019
75
11

Comparison of cerebellar ataxias: A three-year prospective longitudinal assessment.
Yi-chung Lee, Yi-chu Liao, Po-shan Wang, I-Hui Lee, Kon-ping Lin, Bing-wen Soong. Mov Disord 2011
45
8

Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
Tao Zu, Lisa A Duvick, Michael D Kaytor, Michael S Berlinger, Huda Y Zoghbi, H Brent Clark, Harry T Orr. J Neurosci 2004
195
8

A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan.
Kenichi Yasui, Ichiro Yabe, Kunihiro Yoshida, Kazuaki Kanai, Kimihito Arai, Mizuki Ito, Osamu Onodera, Shigeru Koyano, Eiji Isozaki, Setsu Sawai,[...]. Orphanet J Rare Dis 2014
24
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.